Provided by Tiger Trade Technology Pte. Ltd.

HENGRUI PHARMA

50.200
+4.60010.09%
Volume:13.48M
Turnover:655.49M
Market Cap:333.18B
PE:36.41
High:50.400
Open:46.080
Low:45.380
Close:45.600
52wk High:94.869
52wk Low:43.020
Shares:6.64B
HK Float Shares:258.00M
Volume Ratio:5.00
T/O Rate:5.22%
Dividend:0.23
Dividend Rate:0.47%
EPS(LYR):1.379
ROE:12.46%
ROA:7.02%
PB:4.42
PE(LYR):36.41
PS:9.10

Loading ...

AH Share Premium and Deviation Data for July 8th

Stock News
·
Jul 08

Movement Alert|Hengrui Medicine Rises 3.6% in Regular Trading, Proprietary Anti-Tumor Drug SHR-4685 Approved for Clinical Trials

Market Focus
·
Jul 08

Are "Old Economy" Stocks Signaling a Market Shift?

Deep News
·
Jul 06

AH Share Premium and Deviation Data for July 6th

Stock News
·
Jul 06

Movement Alert|Hengrui Pharma Rises 4.01% in Regular Trading, Pharmaceutical Sector Rallies Amid Multiple Drug Approval Catalysts

Market Focus
·
Jul 06

AH Share Premium and Deviation Rankings for July 3rd

Stock News
·
Jul 03

Movement Alert|Hengrui Pharma Rises 3.2% in Regular Trading, Multiple New Drug Approvals and Priority Review Catalyze Gains

Market Focus
·
Jul 03

Hengrui Pharma Gets Nod to Trial Drug Combination for Hepatocellular Carcinoma

MT Newswires Live
·
Jul 03

Hengrui Pharma Reports Cumulative Share Buyback Totaling 13.47 Million A-Shares as of June 30

Stock News
·
Jul 02

Hengrui Pharma Gains Regulatory Nod for Clinical Trials of Three Drug Candidates

Stock News
·
Jul 02

HENGRUI PHARMA Keeps H-Share Capital Steady, Ups A-Share Treasury Stock via RMB 66.1 Million Buy-back in June

Bulletin Express
·
Jul 02

Hengrui Pharma Shares Surge Over 6% on New Drug Indication Approval and International Expansion Success

Stock News
·
Jul 02

Movement Alert|Hengrui Pharma Rises 3.72% in Regular Trading, Pharmaceutical Sector Rally and Multiple Drug Approvals Drive Gains

Market Focus
·
Jul 02

AH Share Premium and Deviation Rankings as of July 1st Close

Stock News
·
Jul 01

AH Share Premium and Deviation Rankings as of June 30th Close

Stock News
·
Jun 30

AH Share Premium and Deviation Data for June 29th

Stock News
·
Jun 29

Movement Alert|Hengrui Pharma Rises 3.02% in Regular Trading, Pharma Sector Rallies as Multiple Regulatory Milestones Boost Sentiment

Market Focus
·
Jun 29

AH Share Premium and Deviation Rankings for June 26

Stock News
·
Jun 26

Hengrui Pharma Gets Nod to Trial HRS-4508 Tablets As Advanced Tumor Treatment; Shares Down 4%

MT Newswires Live
·
Jun 26

Hengrui Pharmaceuticals Unit Wins China Approval to Expand Indication of Cancer Drug

MT Newswires Live
·
Jun 26